BLSFY (BLSFY) Stock Price & Analysis
BLSFY (BLSFY) rose 4.48% to USD 115.07 as of June 10, 2026 at 04:22 UTC, according to Nexqual real-time market data.
BLSFY last closed at USD 110.14; the session ranged USD 115.07–115.07 on volume of 6 shares. Market capitalization is $10.08B, with a 52-week range of USD 65.39–115.07 (PNK). Source: Nexqual, June 10, 2026 at 04:22 UTC.
Key Statistics (as of June 10, 2026 at 04:22 UTC)
| Price | USD 115.07 |
|---|---|
| Change | ▲ 4.48% (up) |
| Previous Close | USD 110.14 |
| Open | USD 115.07 |
| Day Range | USD 115.07 – 115.07 |
| 52-Week Range | USD 65.39 – 115.07 |
| Volume | 6 shares |
| Market Cap | $10.08B |
| Exchange | PNK |
Technical Analysis (BLSFY)
Nexqual's technical model rates BLSFY "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 04:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.13 (neutral) |
| vs SMA50 | Above (USD 105.39) |
| MACD | 1.59 (positive) |
Analyst Ratings (BLSFY)
Wall Street analysts rate BLSFY "None", per Nexqual as of June 10, 2026 at 04:22 UTC.
| Consensus Rating | None |
|---|
Earnings (BLSFY)
Source: Nexqual, June 10, 2026 at 04:22 UTC.
Financials & Fundamentals (BLSFY)
| Total Revenue | $16.61B |
|---|---|
| Revenue Growth (YoY) | +4.00% |
| Gross Margin | +38.23% |
| Operating Margin | +6.27% |
| Profit Margin | +1.78% |
| ROE | +3.43% |
| Debt / Equity | 9.45 |
| Current Ratio | 2.14 |
| Total Cash | $1.08B |
| Total Debt | $1.08B |
| Free Cash Flow | $48.06M |
Source: Nexqual, June 10, 2026 at 04:22 UTC.
Financial Health Score (BLSFY)
Nexqual rates BLSFY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 04:22 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 6% |
| Balance Sheet | Strong — $1.08B cash vs $1.08B debt |
| Cash Flow | Mixed — FCF $48M, slim 0.3% margin |
| Efficiency | Weak — ROE 3%, ROA 3.7% |
Ownership (BLSFY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 87.62M |
| Float | 87.21M |
Source: Nexqual, June 10, 2026 at 04:22 UTC.
Leadership (BLSFY)
BLSFY is led by Tania Jillian Archibald, MD, CEO & Director, per Nexqual as of June 10, 2026 at 04:22 UTC.
| MD, CEO & Director | Tania Jillian Archibald |
|---|---|
| Chief Financial Officer | David Fallu BBUS, FFIN, LLB (Hons) (age 48) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDNNY | Boliden AB | USD 109.64 | ▼ 3.05% |
| ASXFY | ASX, Ltd. | USD 33.31 | ▼ 0.03% |
| ANSLY | Ansell Ltd. | USD 78.77 | ▲ 5.9% |
| GJNSY | Gjensidige Forsikring Asa | USD 25.95 | ▼ 0.38% |
| CSXXY | CAR GROUP LTD | USD 38.7 | ▲ 3.2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:22 UTC. This page is informational and not investment advice.